
Nuvation Bio NUVB
$ 4.29
-2.94%
Annual report 2025
added 03-02-2026
Nuvation Bio DIO Ratio 2011-2026 | NUVB
Quarterly DIO Ratio Nuvation Bio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85.3 | 10 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 85.3 | 10 | 47.7 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Veracyte
VCYT
|
68 | $ 30.92 | -5.73 % | $ 2.43 B | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Avid Bioservices
CDMO
|
102 | - | - | $ 789 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
46.7 | $ 12.67 | -9.24 % | $ 1.92 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
43.5 | $ 321.51 | -2.03 % | $ 42.1 B | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 19.46 | -0.36 % | $ 910 M | ||
|
Amarin Corporation plc
AMRN
|
292 | $ 14.23 | -2.97 % | $ 5.91 B |